1. Ayling, RM, Kok, K. Faecal calprotectin. Adv Clin Chem 2018; 87: 161–190.
Google Scholar | Crossref | Medline2. National Institute for Health and Care Excellence . Faecal calprotectin tests for inflammatory diseases of the bowel [DG11]. www.nice.org.uk/guidance/dg11. (2013, accessed 21 July 2021).
Google Scholar3. National Institute for Health and Care Excellence . The new faecal calprotectin care pathway. https://www.nice.org.uk/sharedlearning/the-new-faecal-calprotectin-care-pathway. (2018, accessed 21 July 2021).
Google Scholar4. Arasaradnam, RP, Brown, S, Forbes, A. Guidelines for the investigation of chronic diarrhoea in adults: British society of gastroenterology. 3rd edition. Gut 2018; 67: 1380–1399.
Google Scholar | Crossref | Medline5. Whitehead, SJ, French, J, Brooks, MJ, et al. Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits. Ann Clin Biochem. 2013; 50: 53–61.
Google Scholar | SAGE Journals | ISI6. National Institute for Health and Care Excellence . Quantitative faecal immunochemical tests to guide referral for colorectal cancer in Primary Care [DG30]. www.nice.org.uk/guidance/dg30. (2007, accessed 21 July 2021).
Google Scholar7. Mowat, C, Digby, J, Strachan, JA, et al. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to Primary Care with bowel symptoms. Gut 2016; 65: 1463–1469.
Google Scholar | Crossref | Medline | ISI8. Dai, C, Jiang, M, Sun, M-J, et al. Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: a systematic review and meta-analysis. Gastroenterol Hepatol 2018; 33: 990–997.
Google Scholar | Crossref9. Rutter, MD, East, J, Rees, CJ, et al. British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut 2020; 69: 201–223.
Google Scholar | Crossref | Medline10. Nakarai, A, Kato, J, Hiraoka, S, et al. Evaluation of mucosal healing f ulcerative colitis by a quantitative fecal immunochemical test. Am J Gastroenterol 2013; 108: 83–89.
Google Scholar | Crossref | Medline | ISI11. Sandhu, K, Naik, S, Ayling, RM. Use of faecal immunochemical test as an alternative to faecal calprotectin in children. Ann Clin Biochem 2021; 58: 230–235.
Google Scholar | SAGE Journals | ISI12. Von Roon, A, Karamountzos, L, Purkayastha, S, et al. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 2007; 102: 803–813.
Google Scholar | Crossref | Medline | ISI13. Ayling, RM, Machesney, M. Service evaluation of faecal immunochemical testing introduced for use in North East London for patients at low risk of colorectal cancer. J Clin Path 2021; 74: 163–166.
Google Scholar | Crossref | Medline14. D’Souza, N, Delisle, TG, Chen, M, et al. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study. Gut 2020; 70: 1130–1138.
Google Scholar | Crossref | Medline15. Elias, SG, Kok, L, de Wit, NJ, et al. Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up of primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic study. BMC Med 2016; 14: 141.
Google Scholar | Crossref | Medline